Skip to main content
ACOG ACSM 2024 Main banner
Back

Industry Abstract

OFFICE PRACTICE

Use of Virtual Patient Education to Improve Provider Compliance with Hereditary Genetic Cancer Assessment Guidelines and Genetic Testing in a Community OB/GYN Setting - IP03-F

Saturday, May 18, 2024
1:15 PM – 2:15 PM PDT
Location: Hall C
Authors:
Richard Waldman MD; Mark DeFrancesco MD; John Feltz MD; Daniel Welling MD; Wade Neiman MD

Introduction:

Hereditary cancer risk assessment (HCRA) is an essential component of women’s healthcare, yet many patients seen in obstetrics and gynecology (OB/Gyn) practices who meet guideline criteria for genetic testing do not get tested. We implemented virtual patient education (vPE) via a video or video with tele-genetic counseling in community OB/Gyn practices and evaluated the impact of vPE on genetic testing rates, and hence comprehensive HCRA.

Methods:

Over an 8-week pre-intervention period, completion of each step of existing HCRA processes at five practices was assessed. Providers then implemented (3-4 weeks) and practiced using (≥4 weeks) an online patient screening tool (MyGeneHistory) and vPE. HCRA and vPE metrics were collected during a 4-to-8-week post-intervention period. Rates were compared using logistic regression and are reported with 95% exact confidence intervals (CI).

Results:

At pre- and post-intervention, clinics saw 5795 and 5135 unique patients, respectively. The percent of patients who met guidelines for genetic testing and were then offered testing, as well as those who then completed testing, was significantly higher post-intervention (offered: 89.1%, CI 87.3%-90.8%; completed: 34.2%, CI 31.6%-36.8%) than pre-intervention (offered: 59.1%, CI 56.3%-61.9%; completed: 16.0%, CI 13.9%-18.2%) (p-values < 0.001). Thirty-eight of 39 providers completed a satisfaction survey, with most agreeing or strongly agreeing that online screening helped in meeting ACOG guidelines recommending HCRA for all patients (92%), vPE helped in delivering standard of care for HCRA (84%), and vPE was easily incorporated (68.5%). Conclusion/Implications:

Online screening and vPE improved genetic testing rates while helping providers meet ACOG HCRA guidelines.
Disclosure(s):
Royce T. Adkins, MD: Myriad Genetics: Consultant (Ongoing)
Richard Waldman, MD: Myriad: Grant/Research Support (Ongoing)
Mark S. DeFrancesco, MD: Myriad: Grant/Research Support (Terminated, July 1, 2022)
John P. Feltz, MD: No financial relationships to disclose
Daniel Welling, MD: Myriad Genetics: Grant/Research Support (Ongoing); Women's Health CT: Grant/Research Support (Ongoing)
Wade A. Neiman, MD: Cooper Surgical: Consultant (Ongoing); Myriad Genetics: Grant/Research Support (Ongoing)